EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Transcriptomic and proteomic analysis stratifies patients with axial spondyloarthritis based on disease activity, structural damage and radiographic progression

Laura Cuesta-López, Iván Arias-de la Rosa iD, Carlos Pérez-Sánchez, Ariana Barbera-Betancour, Miriam Ruiz-Ponce, Antonio Manuel Barranco, Pedro Ortiz-Buitrago, Lourdes Ladehesa-Pineda, María Ángeles Puche-Larrubia iD, Jesus Eduardo Martín-Salazar, Elena Moreno-Caño, María Carmen Ábalos-Aguilera und 5 weitere

RMD Open · 2026-01 · 12 (1) · e006136

DOI: 10.1136/rmdopen-2025-006136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RMD Open, online erschienen am 27.01.2026. Verfasst von Laura Cuesta-López und 16 weiteren Autor:innen. Beteiligte Einrichtung: University of Córdoba, Córdoba, Spain. Hauptthemen laut MEDLINE: Proteomics, Axial Spondyloarthritis, Gene Expression Profiling, Transcriptome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Instituto de Salud Carlos III, European Union and Minister of Science, Innovation and Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To identify clusters of highly correlated genes enriched in biological functions and specific molecular pathways involved in the pathogenesis of radiographic damage in axial spondyloarthritis (axSpA) and to discover molecular biomarkers of radiographic progression and disease severity.

Methods

A total of 144 patients with axSpA were included. First, RNA from peripheral blood mononuclear cells was sequenced in a cohort of 24 patients with axSpA. Hub genes were measured in a n=60 validation cohort through microfluidic PCR. A 5-year follow-up enabled the classification of the patients into fast/moderate or slow progressors. Machine learning approaches were applied to identify a predictive biomarker of progression by integrating gene expression data with clinical variables. An independent cohort of 60 patients with axSpA, with spine radiographs taken 5 years prior, underwent serum proteomic analysis using a Proximity Extension Assay.

Results

Unsupervised clustering analysis using transcriptomics revealed two distinct groups of patients with axSpA, differentiated by their clinical profiles. Weight gene correlation network analysis identified six gene modules differentially expressed between the two clusters. Patients in cluster 2 exhibited higher disease activity, greater functional impairment and more structural damage. Molecular alterations linked to structural damage revealed a specific circulating inflammatory proteome profile associated with disease severity. A predictive model composed of two genes and basal total modified Stoke Ankylosing Spondylitis Spinal Score emerged as a key biomarker for identifying moderate-to-fast radiographic progression.

Conclusions

This study identified molecular pathways involved in radiographic damage and discovered potential proteomic biomarkers of disease severity and transcriptomic predictors of radiographic progression in axSpA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsAxial SpondyloarthritisGene Expression ProfilingTranscriptomeProteomeHumansDisease ProgressionFemaleMaleBiomarkersAdultSeverity of Illness IndexRadiographyMiddle AgedComputational Biology

Stichwörter der Autor:innen

Axial SpondyloarthritisBiomarkersInflammationMachine Learning

Substanzen

BiomarkersProteome

Autor:innen und Institutionen

  • University of Córdoba, Córdoba, Spain.
  • Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Córdoba, Spain.
  • Reina Sofia University Hospital, Córdoba, Spain.
  • Department of Gastroenterology, Hospital General de Tomelloso, Tomelloso, Spain.
  • Instituto de Investigación Sanitaria de Castilla-La Mancha, Toledo, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas yDigestivas, Toledo, Spain.

ORCID-Profile: Iván Arias-de la Rosa, María Ángeles Puche-Larrubia, Clementina López-Medina, Nuria Barbarroja

Förderung

  • Instituto de Salud Carlos III
  • European Union and Minister of Science, Innovation and Universities

Zitieren

APA

Cuesta-López, L., Arias-de la Rosa, I., Pérez-Sánchez, C., Barbera-Betancour, A., Ruiz-Ponce, M., Barranco, A. M., Ortiz-Buitrago, P., Ladehesa-Pineda, L., Puche-Larrubia, M. Á., Martín-Salazar, J. E., Moreno-Caño, E., Ábalos-Aguilera, M. C., Lopez-Pedrera, C., Escudero-Contreras, A., Collantes-Estévez, E., López-Medina, C., & Barbarroja, N. (2026). Transcriptomic and proteomic analysis stratifies patients with axial spondyloarthritis based on disease activity, structural damage and radiographic progression. RMD Open, 12(1), e006136. https://doi.org/10.1136/rmdopen-2025-006136

Vancouver

Cuesta-López L, Arias-de la Rosa I, Pérez-Sánchez C, Barbera-Betancour A, Ruiz-Ponce M, Barranco AM, et al. Transcriptomic and proteomic analysis stratifies patients with axial spondyloarthritis based on disease activity, structural damage and radiographic progression. RMD Open. 2026;12(1):e006136. doi:10.1136/rmdopen-2025-006136

BibTeX
@article{CuestaLpez2026,
  author = {Cuesta-López, Laura and Arias-de la Rosa, Iván and Pérez-Sánchez, Carlos and Barbera-Betancour, Ariana and Ruiz-Ponce, Miriam and Barranco, Antonio Manuel and Ortiz-Buitrago, Pedro and Ladehesa-Pineda, Lourdes and Puche-Larrubia, María Ángeles and Martín-Salazar, Jesus Eduardo and Moreno-Caño, Elena and Ábalos-Aguilera, María Carmen and Lopez-Pedrera, Chary and Escudero-Contreras, Alejandro and Collantes-Estévez, Eduardo and López-Medina, Clementina and Barbarroja, Nuria},
  title = {Transcriptomic and proteomic analysis stratifies patients with axial spondyloarthritis based on disease activity, structural damage and radiographic progression},
  journal = {RMD Open},
  year = {2026},
  volume = {12},
  number = {1},
  pages = {e006136},
  doi = {10.1136/rmdopen-2025-006136}
}
Kostenlos starten →